Similar companies
Are Members of Congress Buying or Selling Cytokinetics?
1 member of the U.S. Congress has traded Cytokinetics (CYTK) stock in the past 90 days, all purchases. Congressional trades are reported under the STOCK Act and are typically disclosed within 45 days of the transaction.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the CYTK AI Score. For corporate insider activity, see CYTK insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
CYTK Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Gilbert Cisneros | Jun 30, 2026 | Buy | $1K – $15K |
| Lisa McClain | Jun 11, 2025 | Buy | $1K – $15K |
Frequently Asked Questions: Cytokinetics Congress Trading
In the past 90 days, members of Congress have made 1 purchase and 0 sales of CYTK stock. The net buying may reflect confidence in the stock. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Gilbert Cisneros bought Cytokinetics (CYTK) stock most recently, on June 30, 2026.
The estimated net value of congressional trades in Cytokinetics over the past 2 years is positive, at $16,000, meaning members of Congress have on balance bought more than they have sold.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
